Gdański Uniwersytet Medyczny – najstarsza oraz największa w północnej Polsce uczelnia medyczna.

During the past decade, Medical University of Gdansk conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 13 clinical trials were completed, i.e. on average, 26% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 5 clinical trials were completed. i.e. 18.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical University of Gdansk" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 26 trials, followed by "Medical University of Gdansk" with 25 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Medical University of Warsaw" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical University of Gdansk" #1 collaborator was "ETOP IBCSG Partners Foundation" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator, "Jagiellonian University" with 3 trials as a collaborator and "Medical University of Silesia" with 3 trials as a collaborator. Other collaborators include 98 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Medical University of Gdansk" are "Breast Cancer" (11 trials), "Lung Cancer" (5 trials), "Non-Small Cell Lung Cancer" (3 trials), "Aortic Valve Stenosis" (2 trials) and "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "Medical University of Gdansk" in a lesser frequency.

Most popular intervention types in "Medical University of Gdansk" are "Drug" (50 trials), "Radiation" (17 trials), "Device" (14 trials), "Procedure" (14 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (11 trials), "Placebo" (8 trials), "conventional surgery" (5 trials), "cisplatin" (4 trials) and "adjuvant therapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Medical University of Gdansk" are 74 trials for "All" genders, 14 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 30 active trials in "Medical University of Gdansk". 1 are not yet recruiting, 13 are recruiting, 15 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 46 completed trials in Medical University of Gdansk, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Medical University of Gdansk, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 21 trials that are defined as “Not Applicable".

Medical University of Gdansk has several departments that took part in Clinical trials: "Medical University of Gdansk - Departament of Anesthesiology and Intensive Care" - 11 trials, "First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland" - 5 trials, "Institute of Internal Diseases University of Medicine" - 4 trials, "University Clinical Center in Gdansk, Teaching Department of Hematology and Transplantology" - 4 trials, "Hematology and Transplantology Clinic, University Clinic Centre - Medical University Hospital" - 3 trials, "Department of Hypertension and Diabetology, Medical University of Gdansk" - 3 trials, "Department of Psychiatry, Medical University of Gdańsk" - 2 trials, "Medical University of Gdańsk Faculty of Health Science" - 2 trials